Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$4.02 - $10.43 $40,320 - $104,612
-10,030 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$8.43 - $20.9 $156,730 - $388,572
-18,592 Reduced 64.96%
10,030 $91,000
Q4 2021

Jan 27, 2022

SELL
$19.26 - $30.08 $1,656 - $2,586
-86 Reduced 0.3%
28,622 $586,000
Q3 2021

Oct 29, 2021

BUY
$24.86 - $35.02 $47,333 - $66,678
1,904 Added 7.1%
28,708 $733,000
Q2 2021

Jul 26, 2021

BUY
$22.3 - $36.02 $89,958 - $145,304
4,034 Added 17.72%
26,804 $937,000
Q1 2021

Apr 27, 2021

BUY
$26.38 - $51.15 $105,678 - $204,906
4,006 Added 21.35%
22,770 $758,000
Q4 2020

Jan 25, 2021

BUY
$10.5 - $28.5 $197,022 - $534,774
18,764 New
18,764 $487,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.